|
PT72878B
(en)
|
1980-04-24 |
1983-03-29 |
Merck & Co Inc |
Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
|
|
AU7686891A
(en)
|
1990-04-05 |
1991-10-30 |
American National Red Cross, The |
A protein family related to immediate-early protein expressed by human endothelial cells during differentiation
|
|
US5869486A
(en)
*
|
1995-02-24 |
1999-02-09 |
Ono Pharmaceutical Co., Ltd. |
Fused pyrimidines and pyriazines as pharmaceutical compounds
|
|
US6060272A
(en)
|
1997-05-07 |
2000-05-09 |
Human Genome Sciences, Inc. |
Human G-protein coupled receptors
|
|
US6310078B1
(en)
*
|
1998-04-20 |
2001-10-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted amino acids as erythropoietin mimetics
|
|
AU5575299A
(en)
|
1998-08-19 |
2000-03-14 |
Millennium Pharmaceuticals, Inc. |
14274 receptor, a g-protein coupled receptor related to the edg receptor family
|
|
DE19846979A1
(de)
|
1998-09-11 |
2000-03-23 |
Max Delbrueck Centrum |
G-Protein gekoppelter Rezeptor EDG6 und seine Verwendung
|
|
CA2348688A1
(en)
|
1998-10-13 |
2000-04-20 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human g protein-coupled receptors
|
|
KR20080104062A
(ko)
|
1998-11-20 |
2008-11-28 |
아레나 파마슈티칼스, 인크. |
사람의 오르판 ｇ 단백질 커플링 수용체
|
|
US6323333B1
(en)
|
1999-04-05 |
2001-11-27 |
Smithkline Beecham Corporation |
Mouse EDG1
|
|
WO2001004139A2
(en)
|
1999-07-13 |
2001-01-18 |
Smithkline Beecham Corporation |
Human axor29 receptor
|
|
GB9923890D0
(en)
|
1999-10-08 |
1999-12-08 |
Pfizer Ltd |
Novel polypeptide
|
|
CA2401454A1
(en)
|
2000-03-03 |
2001-09-13 |
Incyte Genomics, Inc. |
G-protein coupled receptors
|
|
AU4251301A
(en)
|
2000-03-24 |
2001-10-03 |
Bayer Aktiengesellschaft |
Regulation of human nerve growth factor-elated g protein-coupled receptor
|
|
WO2001073021A1
(fr)
|
2000-03-28 |
2001-10-04 |
Takeda Chemical Industries, Ltd. |
Nouvelle proteine receptrice couplee a une proteine g et adn associe
|
|
AU2001270489B2
(en)
|
2000-04-26 |
2007-03-15 |
Sanofi-Aventis Deutschland Gmbh |
EDG8 receptor, its preparation and use
|
|
DE10028901A1
(de)
|
2000-06-10 |
2001-12-20 |
Michael Brues |
Arminosäuresequenz
|
|
AU2001273541A1
(en)
|
2000-07-17 |
2002-01-30 |
Genaissance Pharmaceuticals, Inc. |
Haplotypes of the edg6 gene
|
|
AU2001288563A1
(en)
|
2000-08-31 |
2002-03-13 |
University Of Connecticut |
Regulation of angiogenesis via modulation of edg receptor mediated signal transduction comprising sphingosine-1-phosphate administration
|
|
AU2002221810B2
(en)
|
2000-11-07 |
2005-06-23 |
Novartis Ag |
Indolylmaleimide derivatives as protein kinase C inhibitors
|
|
US7521192B2
(en)
*
|
2001-04-18 |
2009-04-21 |
Rigel Pharmaceuticals, Inc. |
EDG: modulators of lymphocyte activation and migration
|
|
MXPA04001287A
(es)
|
2001-08-10 |
2004-05-27 |
Wyeth Corp |
Ensayo de receptor unido a proteina g.
|
|
US7479504B2
(en)
|
2002-01-18 |
2009-01-20 |
Merck & Co., Inc. |
Edg receptor agonists
|
|
WO2004078163A2
(en)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
PE20040079A1
(es)
|
2002-04-03 |
2004-04-19 |
Novartis Ag |
Derivados de indolilmaleimida
|
|
US20030225288A1
(en)
|
2002-04-12 |
2003-12-04 |
Millennium Pharmaceuticals, Inc. |
Imidazolidine compounds
|
|
JP2005533852A
(ja)
|
2002-07-18 |
2005-11-10 |
セレテック エルエルシー |
Ｅｄｇ−１受容体に関連した症状の治療方法
|
|
BR0314126A
(pt)
|
2002-09-20 |
2005-06-28 |
Pfizer Prod Inc |
Ligandos de amida acìclica e sulfonamida para o receptor de estrogênio
|
|
WO2004035538A1
(en)
|
2002-10-15 |
2004-04-29 |
Merck & Co., Inc. |
Process for making azetidine-3-carboxylic acid
|
|
JP2006514021A
(ja)
|
2002-12-09 |
2006-04-27 |
ザ・ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システム |
Ｊａｎｕｓチロシンキナーゼ３（Ｊａｋ３）を選択的に阻害するための方法
|
|
BRPI0410439A
(pt)
|
2003-05-19 |
2006-06-06 |
Irm Llc |
compostos e composições imunossupressoras
|
|
US7501538B2
(en)
|
2003-08-08 |
2009-03-10 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
|
CN1874991A
(zh)
*
|
2003-08-29 |
2006-12-06 |
小野药品工业株式会社 |
能够结合s1p受体的化合物及其药物用途
|
|
EP1661881B1
(en)
*
|
2003-08-29 |
2014-12-17 |
Ono Pharmaceutical Co., Ltd. |
Compound capable of binding s1p receptor and pharmaceutical use thereof
|
|
JPWO2005028667A1
(ja)
|
2003-09-19 |
2006-11-30 |
独立行政法人理化学研究所 |
ヒト肥満細胞で発現するｇ蛋白質共役型受容体を標的とした薬剤およびそのスクリーニング方法
|
|
EP1524265A1
(en)
|
2003-10-15 |
2005-04-20 |
Newron Pharmaceuticals S.p.A. |
Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors
|
|
JP2007513082A
(ja)
*
|
2003-11-10 |
2007-05-24 |
シエーリング アクチエンゲゼルシャフト |
Ｃｃｒ−５アンタゴニストとして有用なベンジルエーテルアミン化合物
|
|
NZ546058A
(en)
|
2004-01-12 |
2010-09-30 |
Ym Biosciences Australia Pty |
Benzimidazole and other fused ring derivatives as selective janus kinase inhibitors
|
|
US20060057559A1
(en)
*
|
2004-06-23 |
2006-03-16 |
Rigel Pharmaceuticals, Inc. |
High-throughput cell migration screening assay
|
|
US7611851B2
(en)
|
2004-07-27 |
2009-11-03 |
Merck & Co., Inc. |
Canis sphingosine 1-phosphate receptor isoform 1
|
|
KR20140095109A
(ko)
|
2004-11-29 |
2014-07-31 |
노파르티스 아게 |
Ｓ１ｐ 수용체 효능제의 투여 용법
|
|
CN101119714A
(zh)
*
|
2005-02-14 |
2008-02-06 |
弗吉尼亚大学专利基金会 |
含有由氨基和苯基取代的环烷基和5元杂环的1-磷酸鞘氨醇激动剂
|
|
US20090176776A1
(en)
|
2005-10-21 |
2009-07-09 |
University Of Alabama At Birmingham |
Small molecule inhibitors of hiv-1 capsid assembly
|
|
WO2007139946A2
(en)
|
2006-05-25 |
2007-12-06 |
University Of Tennessee Research Foundation |
Gpcr ligands identified by computational modeling
|
|
US7655396B1
(en)
*
|
2006-09-29 |
2010-02-02 |
Allergan, Inc. |
Methods for detecting receptor modulator activity
|
|
US20080108077A1
(en)
*
|
2006-11-07 |
2008-05-08 |
Stephanie Chissoe |
Genes associated with rheumatoid arthritis
|
|
JP2009007341A
(ja)
*
|
2007-06-01 |
2009-01-15 |
Mitsubishi Tanabe Pharma Corp |
医薬組成物
|
|
ES2360929T3
(es)
*
|
2007-09-20 |
2011-06-10 |
Amgen Inc. |
Derivados del ácido 1-(4-(4-bencilbenzamido)-bencil)azetidin-3-carboxílico y compuestos relacionados como moduladores del receptor s1p para el tratamiento de trastornos inmunitarios.
|
|
WO2009053481A1
(en)
|
2007-10-25 |
2009-04-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Compositions and methods for modulating nk and t cell trafficking
|
|
GB0723794D0
(en)
|
2007-12-05 |
2008-01-16 |
Lectus Therapeutics Ltd |
Potassium ion channel modulators and uses thereof
|
|
UY31631A1
(es)
|
2008-02-06 |
2009-09-30 |
|
Nuevos derivados de 7-fenil-7h-pirrolo-[2,3d]-pirimidin-2-il-amino, sales de los mismos, procesos para su preparacion, composiciones farmacéuticas que los comprenden y aplicaciones
|
|
US20100324086A1
(en)
|
2008-02-19 |
2010-12-23 |
Novasaid Ab |
Compounds and methods
|
|
WO2009137081A2
(en)
|
2008-05-07 |
2009-11-12 |
Massachusetts Institute Of Technology |
Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase
|
|
WO2010072712A1
(en)
|
2008-12-23 |
2010-07-01 |
Novartis Ag |
Biaryl benzylamine derivatives
|